CARMIL MB Domain Regulates Actin Capping Protein
2026-09-12
A January 2026 preprint identifies the CARMIL membrane-binding domain as an active regulator rather than a passive membrane anchor. Its findings suggest that membrane attachment, CP recruitment, membrane release, uncapping, and Arp2/3-dependent actin assembly are coordinated through a dynamic MB–CP interaction.
Spermine Workflows for Ion Channel Research
2026-09-12
Spermine provides a biologically relevant way to probe inward rectifier potassium channel modulation, from voltage-controlled electrophysiology to carefully bounded membrane-fusion experiments. This workflow emphasizes concentration planning, solution handling, orthogonal controls, and clear separation between established channel biology and emerging CLCC1 research.
Thrombin B Chain Fragment in Fibrin Assays
2026-09-11
Use a sequence-defined human thrombin B chain fragment to separate peptide-associated effects from catalytic thrombin biology in fibrin, endothelial, platelet, and vascular workflows. This guide translates fibrin-matrix angiogenesis findings into practical assay controls, preparation parameters, and troubleshooting decisions.
(S)-(+)-Dimethindene maleate: Lab Guide
2026-09-11
This guide explains how to use (S)-(+)-Dimethindene maleate as a research tool for separating M2 muscarinic and H1 histamine receptor contributions in receptor and physiology assays. It is intended for controlled in vitro or ex vivo workflows, not for diagnostic, therapeutic, or medical use, and no directly matched paper evidence for SKU B6734 is assumed.
Sisomicin Workflows for Antibacterial Research
2026-09-10
Build more reliable Sisomicin assays by connecting 30S ribosome activity with paired extracellular, intracellular, and exposure-response measurements. This practical guide distinguishes product-backed conditions from hypothesis-generating workflow adaptations for Gram-negative and Gram-positive infection research.
MMP-2 Responsive Liposomes for Sequential Immunotherapy
2026-09-10
The reference study developed an MMP-2-responsive, dual-targeting liposome that sequentially delivers the PD-1 pathway blockade peptide AUNP-12 and the IDO inhibitor NLG919 in breast cancer models. Its main contribution is the use of tumor-associated protease activity to coordinate target-cell engagement, peptide release, secondary targeting, and immunosuppressive microenvironment remodeling.
gamma-Glu-Cys: From Substrate to Systems Insight
2026-09-09
Discover how gamma-Glu-Cys (γ-Glu-Cys) can function as more than a glutathione precursor: it is a controlled variable for enzyme assays, microbial peptide studies, and plant stress adaptation research. This guide connects molecular design, assay interpretation, and findings from recent Bacillus γ-glutamyl peptide research.
E. coli Uracil-DNA Glycosylase (UDG) Guide
2026-09-09
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, removes uracil residues from single- and double-stranded DNA to help control uracil-containing PCR carryover. It is intended for DNA workflows only and should not be used with RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.
METTL16–SENP3–LTF Drives HCC Ferroptosis Resistance
2026-09-08
Wang et al. identify a METTL16–SENP3–LTF axis that links m6A RNA regulation to iron handling and ferroptosis resistance in hepatocellular carcinoma. The study integrates cellular, organoid, mouse-model, molecular, and clinical analyses, establishing labile iron control as a mechanistic connection between epitranscriptomic regulation and tumor progression.
2',7'-Dichlorofluorescein diacetate for ROS Assays
2026-09-08
Build more reliable intracellular ROS measurement workflows with a cell-permeable, fluorogenic redox probe that translates oxidative activity into green fluorescence. This guide connects practical assay design with the ROS-responsive nanocarrier strategy reported for orthotopic pancreatic cancer, while emphasizing controls, normalization, and interpretation limits.
(Z)-4-Hydroxytamoxifen in Relapse Research
2026-09-07
A translational perspective on how (Z)-4-Hydroxytamoxifen can sharpen estrogen receptor studies while complementary proliferation-tracing models reveal the dormant ecosystems that drive breast cancer relapse.
4μ8C Workflows for ER Stress Mechanism Studies
2026-09-05
Use 4μ8C to isolate IRE1α RNase signaling from broader ER-stress effects in hypoxia, cancer research, and nucleus pulposus cell assays. This workflow pairs branch-selective perturbation with PERK–JAK1–STAT3 readouts, helping distinguish pathway engagement from changes in viability or pyroptosis.
Heat-Not-Burn Product Genotoxicity: Key Evidence
2026-09-05
The 2024 reference study compared a heat-not-burn product with conventional cigarettes using complementary rat and cell-based toxicology assays. Its findings indicate lower cytotoxicity and genotoxicity for the tested heat-not-burn product under the experimental conditions, while also showing why multiple endpoints are needed before making broader safety claims.
Cell Cycle Assay Kit: Practical Flow Cytometry Guide
2026-09-04
Map DNA-content changes, distinguish cell cycle arrest from apoptotic loss, and build a reproducible flow cytometry workflow with PI and RNase A. The approach is especially useful for cancer research cell proliferation studies, including mechanistic follow-up of epigenetic therapies in leukemia models.
Acetylcholine Chloride for Causal Circuit Assays
2026-09-04
Acetylcholine Chloride can do more than reproduce cholinergic responses: it can help researchers separate receptor-level effects from gut–vagus–brain circuit causality. This article presents an assay-design framework grounded in recent Bacteroides fragilis epilepsy research.
470 records 6/32 page Previous Next First page 上5页 678910 下5页 Last page